CY1110948T1 - Μεθοδος διαγνωσης lawsonia intracellularis - Google Patents

Μεθοδος διαγνωσης lawsonia intracellularis

Info

Publication number
CY1110948T1
CY1110948T1 CY20101101071T CY101101071T CY1110948T1 CY 1110948 T1 CY1110948 T1 CY 1110948T1 CY 20101101071 T CY20101101071 T CY 20101101071T CY 101101071 T CY101101071 T CY 101101071T CY 1110948 T1 CY1110948 T1 CY 1110948T1
Authority
CY
Cyprus
Prior art keywords
lawsonia intracellularis
diagnosis method
relates
lawsonia
test kit
Prior art date
Application number
CY20101101071T
Other languages
Greek (el)
English (en)
Inventor
Malik Merza
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04014804A external-priority patent/EP1609870A1/en
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of CY1110948T1 publication Critical patent/CY1110948T1/el

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56922Campylobacter
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CY20101101071T 2004-06-24 2010-11-24 Μεθοδος διαγνωσης lawsonia intracellularis CY1110948T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04014804A EP1609870A1 (en) 2004-06-24 2004-06-24 Method of diagnosing lawsonia intracellularis
EP04027193 2004-11-16
EP05755345A EP1761785B1 (en) 2004-06-24 2005-06-23 Method of diagnosing lawsonia intracellularis

Publications (1)

Publication Number Publication Date
CY1110948T1 true CY1110948T1 (el) 2015-06-10

Family

ID=34971368

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101071T CY1110948T1 (el) 2004-06-24 2010-11-24 Μεθοδος διαγνωσης lawsonia intracellularis

Country Status (21)

Country Link
US (12) US7303891B2 (enExample)
EP (1) EP1761785B1 (enExample)
JP (1) JP2008503737A (enExample)
KR (2) KR101389302B1 (enExample)
CN (1) CN1973205B (enExample)
AR (1) AR049411A1 (enExample)
AT (1) ATE479100T1 (enExample)
AU (1) AU2005269043B2 (enExample)
BR (1) BRPI0512546B1 (enExample)
CA (1) CA2568821C (enExample)
CY (1) CY1110948T1 (enExample)
DE (1) DE602005023157D1 (enExample)
DK (1) DK1761785T3 (enExample)
MX (1) MXPA06015207A (enExample)
MY (1) MY146476A (enExample)
PL (1) PL1761785T3 (enExample)
PT (1) PT1761785E (enExample)
RU (1) RU2400758C2 (enExample)
SI (1) SI1761785T1 (enExample)
TW (1) TW200617174A (enExample)
WO (1) WO2006012949A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY146476A (en) * 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP2200643B1 (en) * 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. A live lawsonia intracellularis vaccine administered in combination with an antibiotic for use in the treatment of lawsonia intracellularis infections in pigs
US10125388B2 (en) 2007-10-31 2018-11-13 Akonni Biosystems, Inc. Integrated sample processing system
ES2534556T3 (es) 2008-07-22 2015-04-24 Intervet International Bv Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
US8518658B1 (en) * 2009-04-27 2013-08-27 University Of South Florida ATP-bioluminescence immunoassay
JP2013505018A (ja) 2009-09-21 2013-02-14 アコーニ バイオシステムズ 磁気溶解方法及び装置
EP2523434A1 (en) 2011-05-11 2012-11-14 10n2 Technologies, Inc. A method for limiting the use of a mobile communications device dependent on the travelling speed
CN103698514B (zh) * 2013-12-17 2015-11-18 广西大学 检测猪胞内劳森氏菌抗体的elisa试剂盒
WO2024260953A1 (en) * 2023-06-23 2024-12-26 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
CN119044482B (zh) * 2024-08-08 2025-11-18 华中农业大学 一种检测胞内劳森菌抗体的阻断elisa试剂盒和方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130232A (en) * 1990-06-12 1992-07-14 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibody immunoassay kit for avian reticuloendotheliosis virus
JP3547022B2 (ja) * 1994-12-16 2004-07-28 富士写真フイルム株式会社 磁気記録媒体
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US5714375A (en) 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
JP2000502054A (ja) * 1995-11-30 2000-02-22 アグリカルチャー ビクトリア サービシーズ ピーティーワイ.エルティーディー. 治療用および診断用の組成物
EP0974660A1 (en) 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle disease virus infectious clones, vaccines and diagnostic assays
CN1260492A (zh) * 1999-11-09 2000-07-19 赵永同 肿瘤预后评估试剂盒及其制备工艺
JP2004529854A (ja) 2000-09-29 2004-09-30 アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
DE60144201D1 (de) 2000-12-20 2011-04-21 Intervet Int Bv Lawsonia intracellularis Impfstoff
JP4079727B2 (ja) 2002-09-06 2008-04-23 セントラル硝子株式会社 光学活性1−(フルオロ、トリフルオロメチルまたはトリフルオロメトキシ置換フェニル)アルキルアミンn−モノアルキル誘導体とその製造方法
EP1570045A4 (en) 2002-10-04 2007-09-05 Univ Minnesota NUCLEIC ACID AND POLYPEPTIDE SEQUENCES FROM LAWSONIA INTRACELLULARIS AND METHOD OF USE
BRPI0507017A (pt) 2004-01-22 2007-06-05 Intervet Int Bv ácido nucleico que codifica uma proteìna de lawsonia intracellularis, fragmento de dna, molécula de dna recombinante, carreador recombinante vivo, célula hospedeira, proteìna de lawsonia intracellularis, uso da mesma, vacina para combater as infecções por lawsonia intracellularis, método para preparação da mesma, e, teste de diagnóstico
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis

Also Published As

Publication number Publication date
US20110275149A1 (en) 2011-11-10
DK1761785T3 (da) 2010-11-08
KR20070026855A (ko) 2007-03-08
EP1761785B1 (en) 2010-08-25
US8114666B2 (en) 2012-02-14
BRPI0512546A (pt) 2008-03-25
CN1973205B (zh) 2012-07-18
US7799562B2 (en) 2010-09-21
KR101306610B1 (ko) 2013-09-11
US20110201787A1 (en) 2011-08-18
ATE479100T1 (de) 2010-09-15
TW200617174A (en) 2006-06-01
MXPA06015207A (es) 2007-03-26
US8021663B2 (en) 2011-09-20
US8007801B1 (en) 2011-08-30
US7303891B2 (en) 2007-12-04
US20110201786A1 (en) 2011-08-18
US8058062B1 (en) 2011-11-15
US8007802B1 (en) 2011-08-30
US20110201790A1 (en) 2011-08-18
SI1761785T1 (sl) 2010-12-31
AR049411A1 (es) 2006-07-26
KR101389302B1 (ko) 2014-04-25
JP2008503737A (ja) 2008-02-07
PT1761785E (pt) 2010-11-10
US20110275148A1 (en) 2011-11-10
US8003107B1 (en) 2011-08-23
US20110201788A1 (en) 2011-08-18
BRPI0512546B1 (pt) 2016-07-19
AU2005269043B2 (en) 2011-10-27
RU2007102426A (ru) 2008-07-27
CN1973205A (zh) 2007-05-30
CA2568821C (en) 2017-02-14
US7635590B2 (en) 2009-12-22
US8114667B2 (en) 2012-02-14
CA2568821A1 (en) 2006-02-09
US20110275147A1 (en) 2011-11-10
US7993649B1 (en) 2011-08-09
US7960174B2 (en) 2011-06-14
DE602005023157D1 (de) 2010-10-07
AU2005269043A1 (en) 2006-02-09
RU2400758C2 (ru) 2010-09-27
WO2006012949A1 (en) 2006-02-09
US20070003991A1 (en) 2007-01-04
PL1761785T3 (pl) 2011-02-28
KR20130012085A (ko) 2013-01-31
US20080102479A1 (en) 2008-05-01
US20100112608A1 (en) 2010-05-06
EP1761785A1 (en) 2007-03-14
US20110033870A1 (en) 2011-02-10
US20110201789A1 (en) 2011-08-18
MY146476A (en) 2012-08-15

Similar Documents

Publication Publication Date Title
CY1110948T1 (el) Μεθοδος διαγνωσης lawsonia intracellularis
EA201100231A1 (ru) Диагностический анализ на основе антител
CY1121536T1 (el) Ανθρωπινα αντισωματα εναντι-αλφα-συνουκλεϊνης
BRPI0714744A8 (pt) Método para diagnosticar uma infecção causada por um microorganismo
CY1118880T1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
BR112017010268A2 (pt) agente de ligação; composição de diagnóstico; kit de diagnóstico; métodos de diagnóstico de uma infecção bacteriana ou de diferenciação entre uma infecção bacteriana e uma infecção de viral; para descartar uma infecção bacteriana em um indivíduo; para descartar uma infecção viral em um indivíduo; para considerar uma infecção bacteriana em um indivíduo; para considerar uma infecção viral em um indivíduo; para distinguir entre uma infecção bacteriana ou mista e uma infecção viral em um indivíduo; para fornecer uma recomendação de tratamento para um indivíduo; para fornecer uma recomendação de teste de diagnóstico para um indivíduo; para descartar uma doença infecciosa; para identificação do tipo de infecção; e dispositivo para o diagnóstico de infecções bacterianas
CY1117631T1 (el) Ανιχνευση της χρησης κανναβεως
DK1651260T3 (da) Lawsonia intracellularis af europæisk oprindelse og vacciner, diagnostiske midler og fremgangsmåder til anvendelse deraf
DE602006007703D1 (de) Verbesserte immuntestverfahren
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
EP3759469A4 (en) INLINE TESTING WITH COLOR DEVELOPMENT FOR DIAGNOSTIC ANALYSIS
FI20012603A0 (fi) Diagnostinen menetelmä
EP4178453A4 (en) Sample collection device, sample collection kit, sample collection system, diagnostic device, and associated methods
AR050213A1 (es) Ensayo de diagnostico ileitis
BR112022020143A2 (pt) Teste de diagnóstico de patógeno
EA200901590A1 (ru) Антитела, применяемые в терапии и диагностике рака
ITRM20040098A1 (it) Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi.
EP1747025A4 (en) METHOD FOR THE DIAGNOSIS OF INFECTION DISEASES
DE602006015221D1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
DE502006004301D1 (de) Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum
Gebhart et al. Comparative study of serology assays for equine proliferative enteropathy.
FR2841988B1 (fr) Methode de diagnostic serologique comprenant un controle positif de l'introduction d'un serum humain a tester
EP4302086A4 (en) Biochemical medical diagnostic kit
Unger et al. Prevalence of major pig production diseases in 2 provinces of northern Vietnam (Hoa Binh and Vinh Phuc)
Cooke et al. B105 SEPSIS: CARE MODELS AND OUTCOMES: A Distinguishing Feature Of Procalcitonin Elevation In Sepsis Due To Presumed Abdominal Sources